Sign in
4

Changes in Ownership

ORAMED PHARMACEUTICALS INC. Filed Acc 0001213900-21-041711

President and CEO sold 220,000 shares at $20.11 ($4,423,144)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I In the form
KIDRON NADAV President and CEO 2021-08-09 Sale −220,000 $20.11 $4,423,144 648,573 D
Open-market sales · 220,000 sh · avg $20.11 · $4,423,144
Loading xslF345X03/ownership.xml…